Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate
Authors:
Open Access
- 1 September 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 68 (3) , 591-598
Abstract
The relation between gastrointestinal incretin hormones in the control of insulin release and short-term satiety by intestinal carbohydrate was investigated in 8 fasted, healthy male volunteers. Insulin, gastric inhibitory polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and appetite ratings were measured during, and food intake was measured after, intraduodenal infusions of glucose or saline. Studies were conducted under hyperinsulinemic and euglycemic conditions. Raising plasma insulin with intravenous insulin infusion to concentrations slightly above usual postprandial concentrations (356.4 +/- 4.8 pmol/L) had no effect on GIP, GLP-1, or appetite ratings before the intraduodenal infusions began. Intraduodenal glucose infusion resulted in a further increase in plasma insulin to a peak of 779.4 +/- 114.0 pmol/L, caused an early increase in plasma GIP and a later increase in GLP-1 concentrations (P < 0.01), suppressed appetite (P < 0.05), and reduced energy intake (P < 0.01) compared with intraduodenal infusion of saline. There was a close association between the increase in GLP-1 and decrease in appetite. Infusion of octreotide to suppress the release of gastrointestinal hormones prevented the rise in insulin, GIP, and GLP-1 induced by intraduodenal glucose infusion and reversed the suppression of appetite and reduction in energy intake. These results suggest that 1) when infused to result in plasma concentrations slightly above usual postprandial concentrations, insulin does not inhibit its own release and 2) the effects of intraduodenal glucose on appetite may be mediated through the release of GLP-1 and not insulin.Keywords
This publication has 42 references indexed in Scilit:
- Gastric emptying and release of incretin hormones after glucose ingestion in humans.Journal of Clinical Investigation, 1996
- A role for glucagon-like peptide-1 in the central regulation of feedingNature, 1996
- Pharmacodynamic Effects of Sandostatin® in the Gastrointestinal TractDigestion, 1993
- Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and manEuropean Journal of Clinical Investigation, 1992
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987
- Insulin induced overeating in the ratPhysiology & Behavior, 1977
- Levels of Pancreatic Glucagon, Insulin and Glucose during Twenty-Four Hours of the Day in Normal SubjectsHormone and Metabolic Research, 1975
- Duodenal or hepatic-portal glucose perfusion: Evidence for duodenally-based satietyPhysiology & Behavior, 1974
- Hunger elicited in the rat by a single injection of bovine crystalline insulin☆Physiology & Behavior, 1968
- REGULATION OF ENERGY INTAKE AND THE BODY WEIGHT: THE GLUCOSTATIC THEORY AND THE LIPOSTATIC HYPOTHESISAnnals of the New York Academy of Sciences, 1955